BRITS are being urged to look out for symptoms of RSV after an increase in cases of the highly contagious disease. The virus ...

Two new studies suggest that nirsevimab (Beyfortus) is 80% to 89% effective in protecting infants from poor respiratory ...

May 7, 2009 (Baltimore, Maryland) — Mildly premature infants, even those who are nearly full term, are still at high risk for serious respiratory syncytial virus (RSV) infections that require medical ...

The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

An infant immunization for respiratory syncytial virus (RSV) is now available across Canada, but it still has to be paid for ...

The Food and Drug Administration's independent panel of advisors recommended full approval of Pfizer's vaccine that protects infants from respiratory syncytial virus. But the advisory committee raised ...

WASHINGTON -- The U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV). The vaccine would be given ...

Respiratory Syncytial Virus (RSV) is a common virus in babies and often starts with mild cold-like symptoms. For some infants ...

A vaccination programme to tackle respiratory syncytial virus (RSV) is to be extended to cover premature babies born in Northern Ireland. A long-acting injection is to be offered for eligible children ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...